Development/Evaluation of Hybrid Novel Mucosal Vaccines

Frazer, Ian H.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Exploratory/Developmental Grants (R21)
• Project #: 5R21AI046329-02
• Application #: 6170882
• Study Section: Special Emphasis Panel (ZRG1-VACC (01))
• Program Officer: Bradac, James A
• Project Start: 1999-09-30
• Project End: 2002-02-28
• Budget Start: 2000-08-30
• Budget End: 2002-02-28
• Support Year: 2
• Fiscal Year: 2000
• Total Cost: $150,000

Institution

• Name: University of Queensland
• DUNS #: 752898403
• City: Brisbane
• Country: Australia
• Zip Code: 4072

Publications

Dale, C Jane; Liu, Xiaosong Song; De Rose, Robert et al. (2002) Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques. Virology 301:176-87

Liu, W J; Zhao, K N; Gao, F G et al. (2001) Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. Vaccine 20:862-9